Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianbo Jiang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Hematology & Oncology|September 18, 2020
BCMA-targeted immunotherapy for multiple myelomaBo Yu, Tianbo Jiang, Delong Liu
The Journal of Thoracic and Cardiovascular Surgery|June 19, 2012
Massive spontaneous hemorrhage in giant type 1 neurofibromatosis in soft tissue of chest wallKewei Zhang, Jena Song, Wenji Xiong, et al.
Oncoimmunology|October 25, 2019
Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memoryAnja C Bloom, Lewis H Bender, Shweta Tiwary, et al.
Blood|April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cellsXiaoli Wang, David Haylock, Cing Siang Hu, et al.
The Journal of Clinical Investigation|December 21, 2023
Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancerKumiko Nishio, Lise Pasquet, Kaddy Camara, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Hematology & Oncology|September 18, 2020
BCMA-targeted immunotherapy for multiple myelomaBo Yu, Tianbo Jiang, Delong Liu
The Journal of Thoracic and Cardiovascular Surgery|June 19, 2012
Massive spontaneous hemorrhage in giant type 1 neurofibromatosis in soft tissue of chest wallKewei Zhang, Jena Song, Wenji Xiong, et al.
Oncoimmunology|October 25, 2019
Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memoryAnja C Bloom, Lewis H Bender, Shweta Tiwary, et al.
Blood|April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cellsXiaoli Wang, David Haylock, Cing Siang Hu, et al.
The Journal of Clinical Investigation|December 21, 2023
Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancerKumiko Nishio, Lise Pasquet, Kaddy Camara, et al.
Pageof 1